402 related articles for article (PubMed ID: 21360709)
1. Inkjet printing of drug substances and use of porous substrates-towards individualized dosing.
Sandler N; Määttänen A; Ihalainen P; Kronberg L; Meierjohann A; Viitala T; Peltonen J
J Pharm Sci; 2011 Aug; 100(8):3386-3395. PubMed ID: 21360709
[TBL] [Abstract][Full Text] [Related]
2. QR encoded smart oral dosage forms by inkjet printing.
Edinger M; Bar-Shalom D; Sandler N; Rantanen J; Genina N
Int J Pharm; 2018 Jan; 536(1):138-145. PubMed ID: 29183858
[TBL] [Abstract][Full Text] [Related]
3. Printing medicines as orodispersible dosage forms: Effect of substrate on the printed micro-structure.
Planchette C; Pichler H; Wimmer-Teubenbacher M; Gruber M; Gruber-Woelfler H; Mohr S; Tetyczka C; Hsiao WK; Paudel A; Roblegg E; Khinast J
Int J Pharm; 2016 Jul; 509(1-2):518-527. PubMed ID: 26541301
[TBL] [Abstract][Full Text] [Related]
4. Hyperspectral imaging in quality control of inkjet printed personalised dosage forms.
Vakili H; Kolakovic R; Genina N; Marmion M; Salo H; Ihalainen P; Peltonen J; Sandler N
Int J Pharm; 2015 Apr; 483(1-2):244-9. PubMed ID: 25527212
[TBL] [Abstract][Full Text] [Related]
5. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques.
Genina N; Fors D; Vakili H; Ihalainen P; Pohjala L; Ehlers H; Kassamakov I; Haeggström E; Vuorela P; Peltonen J; Sandler N
Eur J Pharm Sci; 2012 Oct; 47(3):615-23. PubMed ID: 22902482
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different substrates for inkjet printing of rasagiline mesylate.
Genina N; Janßen EM; Breitenbach A; Breitkreutz J; Sandler N
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1075-83. PubMed ID: 23563101
[TBL] [Abstract][Full Text] [Related]
7. Visualization and Non-Destructive Quantification of Inkjet-Printed Pharmaceuticals on Different Substrates Using Raman Spectroscopy and Raman Chemical Imaging.
Edinger M; Bar-Shalom D; Rantanen J; Genina N
Pharm Res; 2017 May; 34(5):1023-1036. PubMed ID: 28251424
[TBL] [Abstract][Full Text] [Related]
8. Analytical aspects of printed oral dosage forms.
Edinger M; Jacobsen J; Bar-Shalom D; Rantanen J; Genina N
Int J Pharm; 2018 Dec; 553(1-2):97-108. PubMed ID: 30316794
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional drug printing: a structured review.
Ursan ID; Chiu L; Pierce A
J Am Pharm Assoc (2003); 2013; 53(2):136-44. PubMed ID: 23571620
[TBL] [Abstract][Full Text] [Related]
10. Inkjet printing of paracetamol and indomethacin using electromagnetic technology: Rheological compatibility and polymorphic selectivity.
Kollamaram G; Hopkins SC; Glowacki BA; Croker DM; Walker GM
Eur J Pharm Sci; 2018 Mar; 115():248-257. PubMed ID: 29366961
[TBL] [Abstract][Full Text] [Related]
11. Printing technologies in fabrication of drug delivery systems.
Kolakovic R; Viitala T; Ihalainen P; Genina N; Peltonen J; Sandler N
Expert Opin Drug Deliv; 2013 Dec; 10(12):1711-23. PubMed ID: 24256326
[TBL] [Abstract][Full Text] [Related]
12. Behavior of printable formulations of loperamide and caffeine on different substrates--effect of print density in inkjet printing.
Genina N; Fors D; Palo M; Peltonen J; Sandler N
Int J Pharm; 2013 Sep; 453(2):488-97. PubMed ID: 23769992
[TBL] [Abstract][Full Text] [Related]
13. A step toward development of printable dosage forms for poorly soluble drugs.
Raijada D; Genina N; Fors D; Wisaeus E; Peltonen J; Rantanen J; Sandler N
J Pharm Sci; 2013 Oct; 102(10):3694-704. PubMed ID: 23904182
[TBL] [Abstract][Full Text] [Related]
14. Quantification of Inkjet-Printed Pharmaceuticals on Porous Substrates Using Raman Spectroscopy and Near-Infrared Spectroscopy.
Edinger M; Iftimi LD; Markl D; Al-Sharabi M; Bar-Shalom D; Rantanen J; Genina N
AAPS PharmSciTech; 2019 Jun; 20(5):207. PubMed ID: 31161397
[TBL] [Abstract][Full Text] [Related]
15. Edible solid foams as porous substrates for inkjet-printable pharmaceuticals.
Iftimi LD; Edinger M; Bar-Shalom D; Rantanen J; Genina N
Eur J Pharm Biopharm; 2019 Mar; 136():38-47. PubMed ID: 30630061
[TBL] [Abstract][Full Text] [Related]
16. Printed Drug-Delivery Systems for Improved Patient Treatment.
Sandler N; Preis M
Trends Pharmacol Sci; 2016 Dec; 37(12):1070-1080. PubMed ID: 27992318
[TBL] [Abstract][Full Text] [Related]
17. Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder.
Infanger S; Haemmerli A; Iliev S; Baier A; Stoyanov E; Quodbach J
Int J Pharm; 2019 Jan; 555():198-206. PubMed ID: 30458260
[TBL] [Abstract][Full Text] [Related]
18. Development of Oromucosal Dosage Forms by Combining Electrospinning and Inkjet Printing.
Palo M; Kogermann K; Laidmäe I; Meos A; Preis M; Heinämäki J; Sandler N
Mol Pharm; 2017 Mar; 14(3):808-820. PubMed ID: 28195483
[TBL] [Abstract][Full Text] [Related]
19. 3D Printing of Solid Oral Dosage Forms: Numerous Challenges With Unique Opportunities.
Okafor-Muo OL; Hassanin H; Kayyali R; ElShaer A
J Pharm Sci; 2020 Dec; 109(12):3535-3550. PubMed ID: 32976900
[TBL] [Abstract][Full Text] [Related]
20. 3D screen printing technology enables fabrication of oral drug dosage forms with freely tailorable release profiles.
Enke M; Schwarz N; Gruschwitz F; Winkler D; Hanf F; Jescheck L; Seyferth S; Fischer D; Schneeberger A
Int J Pharm; 2023 Jul; 642():123101. PubMed ID: 37295568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
